Barbara W. Bodem is Director of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 6,900 shares of BMRN, which is worth approximately $459,746. The most recent transaction as insider was on May 21, 2024, when has been sold 4,720 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.9K
0% 3M change
n/a 12M change
Total Value Held $459,746

Barbara W. Bodem Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2024
BUY
Grant, award, or other acquisition
-
4,720 Added 40.62%
6,900 Common Stock
Dec 27 2023
BUY
Grant, award, or other acquisition
-
2,180 Added 50.0%
2,180 Common Stock

Also insider at

TPTX
Turning Point Therapeutics, Inc.
SYNH
Syneos Health, Inc. Healthcare
ENOV
Enovis CORP Industrials
OPCH
Option Care Health, Inc. Healthcare
BWB

Barbara W. Bodem

Director
San Diego, CA

Track Institutional and Insider Activities on BMRN

Follow BIOMARIN PHARMACEUTICAL INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Track Activities on BMRN